Compare Global X NASDAQ 100 Covered Call ETF (QYLD) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X NASDAQ 100 Covered Call ETF vs Tempus AI — how do they compare? Global X NASDAQ 100 Covered Call ETF trades at $18.69 (market cap $8.50B), while Tempus AI trades at $70.35 (market cap $12.77B). The key difference: Tempus AI is the larger of the two by market cap, and Global X NASDAQ 100 Covered Call ETF is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X NASDAQ 100 Covered Call ETF for 50 Days and Tempus AI for 22 Days on average.
| QYLD | TEM | |
|---|---|---|
Market Cap | $8.50B | $12.77B |
Volume | 2,606,214 | 8,980,490 |
Sector | Income / Options Overlay | Broad Market / Factor |
52-Week High | $18.68 | $99.28 |
52-Week Low | $16.70 | $41.55 |
Typical Hold Time | 50 Days | 22 Days |
Enterprise Value | — | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QYLD trades at $18.68 with no daily change, showing a bullish technical trend per moving averages but overbought oscillators. The ETF maintains a high monthly dividend payout of $0.18, though recent news highlights concerns over capped upside and declining option premiums. Support and resistance cluster tightly around $19, indicating potential volatility near current levels.
Outlook remains mixed: high yield appeals for income, but structural limitations risk long-term capital erosion. Key risks include reduced Nasdaq participation and tax implications, while analyst sentiment is divided on sustainability versus growth trade-offs.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
